DBV Technologies S.A. (DBVT) Social Stream



DBV Technologies S.A. (DBVT): $0.81

0.02 (+2.77%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add DBVT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#122 of 347

in industry

DBV TECHNOLOGIES SA (DBVT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering DBVT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-27 1 $14 $2 $8 $0.773 934.93%
2021-12-21 1 $10 $2 $6 $0.773 676.2%
2022-05-03 3 $10 $5 $7.5 $0.773 870.25%
2022-11-04 3 $10 $1.5 $5.75 $0.773 643.86%
2023-05-09 4 $10 $1.5 $5.166 $0.773 568.31%
2023-08-01 4 $10 $4 $7 $0.773 805.56%
2023-11-02 4 $10 $1 $5 $0.773 546.83%

The Trend in the Analyst Price Target


Over the past 25 months, DBVT's average price target has gone down $3.

Over the past 35 weeks, DBVT's average upside potential has been 289.75%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-03 4 10 1.5 5.166 1.44 258.75%
2023-03-08 4 10 1.5 5.166 1.73 198.61%
2023-05-09 4 10 4.0 7.000 1.63 329.45%
2023-08-01 4 10 4.0 7.000 1.61 334.78%
2023-11-02 4 10 1.0 5.000 1.00 400%

DBVT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 3 0 0 1 1 4

The Trend in the Broker Recommendations


Over the past 38 months, DBVT's average broker recommendation rating improved by 0.36.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In terms of how DBV TECHNOLOGIES SA fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1045.04% of that group.
  • DBVT has a greater average analyst price target than 62.61% of all US stocks.
  • DBVT has a greater number of analysts covering the stock than 71.91% of all US stocks.
  • DBV TECHNOLOGIES SA's variance in analysts' estimates is lower than -871.06% of stocks in the small market cap category.

Stocks similar to DBV TECHNOLOGIES SA in the Pharmaceutical Products industry regarding analyst recommendations and price targets are EIGR, OCGN, and ADVM.

Is DBVT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!